Search scope:
排序： Display mode:
Xiaoqing Li, Xinxin Li, Genbei Wang, Yan Xu, Yuanyuan Wang, Ruijia Hao, Xiaohui Ma
Frontiers of Medicine 2018, Volume 12, Issue 6, Pages 688-696 doi: 10.1007/s11684-018-0662-8
Xiao Ke Qing (XKQ) granule has been clinically used to treat type 2 diabetes mellitus (T2DM) for 10This study aims to investigate XKQ mechanisms on diabetes and diabetic liver disease by using the KKAyOur results indicate that XKQ can significantly reduce food and water intake.XKQ treatment also remarkably decreases both the fasting blood glucose and blood glucose in the oralAdditionally, XKQ can significantly decrease the serum alanine aminotransferase level and liver index
Keywords： XKQ type 2 diabetes mellitus KKAy mice PI3K/Akt pathway diabetic liver disease
Title Author Date Type Operation
京公网安备 11010502051620号
